Business Description
HLB BioStep Co Ltd
ISIN : KR7278650007
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | 1.93 | |||||
Interest Coverage | 11.33 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.57 | |||||
Beneish M-Score | -3.14 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.8 | |||||
3-Year EBITDA Growth Rate | -19.5 | |||||
3-Year FCF Growth Rate | -47.6 | |||||
3-Year Book Growth Rate | 18.1 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.54 | |||||
9-Day RSI | 40.6 | |||||
14-Day RSI | 43.01 | |||||
6-1 Month Momentum % | -20.63 | |||||
12-1 Month Momentum % | -16.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.37 | |||||
Quick Ratio | 1.37 | |||||
Days Inventory | 44.63 | |||||
Days Sales Outstanding | 31.13 | |||||
Days Payable | 41.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 19.61 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.75 | |||||
Operating Margin % | 22.9 | |||||
Net Margin % | -8.7 | |||||
FCF Margin % | -28.03 | |||||
ROE % | -4.4 | |||||
ROA % | -2.9 | |||||
ROIC % | 8.89 | |||||
ROC (Joel Greenblatt) % | 37.42 | |||||
ROCE % | 12.74 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.12 | |||||
PB Ratio | 1.5 | |||||
Price-to-Tangible-Book | 1.49 | |||||
EV-to-EBIT | 11 | |||||
EV-to-EBITDA | 9.13 | |||||
EV-to-Revenue | 2.97 | |||||
EV-to-FCF | -11.16 | |||||
Price-to-Net-Current-Asset-Value | 21.26 | |||||
Earnings Yield (Greenblatt) % | 9.08 | |||||
FCF Yield % | -9.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
HLB BioStep Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 56,755.208 | ||
EPS (TTM) (â‚©) | -60.916 | ||
Beta | 0.94 | ||
Volatility % | 59.93 | ||
14-Day RSI | 43.01 | ||
14-Day ATR (â‚©) | 107.743008 | ||
20-Day SMA (â‚©) | 2097.9 | ||
12-1 Month Momentum % | -16.63 | ||
52-Week Range (â‚©) | 1953 - 4705 | ||
Shares Outstanding (Mil) | 84.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HLB BioStep Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HLB BioStep Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
HLB BioStep Co Ltd Frequently Asked Questions
What is HLB BioStep Co Ltd(XKRX:278650)'s stock price today?
When is next earnings date of HLB BioStep Co Ltd(XKRX:278650)?
Does HLB BioStep Co Ltd(XKRX:278650) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |